Structure−Activity Relationships of Novel 2-Substituted Quinazoline Antibacterial Agents
Pei‐Pei Kung(Pfizer (United States)), David J. Ecker(University of Colorado Denver), Jacqueline R. Wyatt(Ionis Pharmaceuticals (United States)), Laura Wilson-Lingardo(Ionis Pharmaceuticals (United States)), Timothy A. Vickers(Ionis Pharmaceuticals (United States)), Lisa M. Risen(Ionis Pharmaceuticals (United States)), P. Dan Cook(Ionis Pharmaceuticals (United States)), Martin D. Casper(Ionis Pharmaceuticals (United States)), Ray Ranken(Ionis Pharmaceuticals (United States)), Kimberley L. Cook(Ionis Pharmaceuticals (United States)), Lawrence B. Blyn(Ionis Pharmaceuticals (United States))
Cited by 226
Related Papers
A Multiubiquitin Chain Is Confined to Specific Lysine in a Targeted Short-Lived Protein
|Science|1989|1.5k
Structure Based Drug Design of Crizotinib (PF-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal–Epithelial Transition Factor (c-MET) Kinase and Anaplastic Lymphoma Kinase (ALK)
|Journal of Medicinal Chemistry|2011|924
Evaluation of 2‘-modified oligonucleotides containing 2‘-deoxy gaps as antisense inhibitors of gene expression
|Journal of Biological Chemistry|1993|770
Analysis of Antibiotic Resistance Genes in Multidrug-Resistant <i>Acinetobacter</i> sp. Isolates from Military and Civilian Patients Treated at the Walter Reed Army Medical Center
|Antimicrobial Agents and Chemotherapy|2006|481
Inhibition of proteolysis and cell cycle progression in a multiubiquitination-deficient yeast mutant.
|Molecular and Cellular Biology|1994|357